Brief: Graphite Bio Posts Q3 Loss Per Share Of $0.28

LENZ Therapeutics

10/11/2021 21:55

Nov 10 (Reuters) - Graphite Bio Inc  GRPH.O :
    * GRAPHITE BIO REPORTS RECENT BUSINESS PROGRESS AND THIRD
QUARTER
2021 FINANCIAL RESULTS
    * Q3 LOSS PER SHARE $0.28

Source text for Eikon:  ID:nBw63rts8a 
Further company coverage:  GRPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))